Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 30, 2014 - Issue 8
885
Views
26
CrossRef citations to date
0
Altmetric
Articles

Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms

, , &
Pages 893-902 | Received 15 Feb 2014, Accepted 08 Jul 2014, Published online: 22 Aug 2014

References

  • Amoureux L, Bador J, Siebor E, Taillefumier N, Fanton A, Neuwirth C. 2012. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. J Cyst Fibros. 12:170–176.
  • Andrews SC, Robinson AK, Rodriguez-Quinones F. 2003. Bacterial iron homeostasis. FEMS Microbiol Rev. 27:215–237.10.1016/S0168-6445(03)00055-X
  • Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol. 24:203–206.10.1046/j.1472-765X.1997.00378.x
  • Campoccia D, Montanaro L, Arciola CR. 2006. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 27:2331–2339.10.1016/j.biomaterials.2005.11.044
  • Cerqueira L, Oliveira JA, Nicolau A, Azevedo NF, Vieira MJ. 2013. Biofilm formation with mixed cultures of Pseudomonas aeruginosa/Escherichia coli on silicone using artificial urine to mimic urinary catheters. Biofouling. 29:829–840.
  • Ciofu O, Hansen CR, Hoiby N. 2013. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med. 19:251–258.10.1097/MCP.0b013e32835f1afc
  • Costerton JW. 1999. Introduction to biofilm. Int J Antimicrob Agents. 11:217–221. Discussion 237–219.10.1016/S0924-8579(99)00018-7
  • Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. 1987. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 41:435–464.10.1146/annurev.mi.41.100187.002251
  • Curtis LT. 2008. Prevention of hospital-acquired infections: review of non-pharmacological interventions. J Hosp Infect. 69:204–219.10.1016/j.jhin.2008.03.018
  • de Vrankrijker AM, Wolfs TF, van der Ent CK. 2010. Challenging and emerging pathogens in cystic fibrosis. Paediatr Respir Rev. 11:246–254.10.1016/j.prrv.2010.07.003
  • Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 15:167–193.10.1128/CMR.15.2.167-193.2002
  • Doyle B, Mawji Z, Horgan M, Stillman P, Rinehart A, Bailey J, Mullin E Jr. 2001. Decreasing nosocomial urinary tract infection in a large academic community hospital. Lippincotts Case Manag. 6:127–136.10.1097/00129234-200105000-00007
  • Elias S, Banin E. 2012. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev. 36:990–1004.
  • Ferrieres L, Hancock V, Klemm P. 2007. Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains. Microbiology. 153:1711–1719.10.1099/mic.0.2006/004721-0
  • Frank DN, Wilson SS, St Amand AL, Pace NR. 2009. Culture-independent microbiological analysis of foley urinary catheter biofilms. PLoS One. 4:e7811.10.1371/journal.pone.0007811
  • Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D. 1992. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis. 11:789–796.10.1007/BF01960877
  • Griffin AS, West SA, Buckling A. 2004. Cooperation and competition in pathogenic bacteria. Nature. 430:1024–1027.10.1038/nature02744
  • Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2:95–108.10.1038/nrmicro821
  • Harrison F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology. 153:917–923.10.1099/mic.0.2006/004077-0
  • Hedlund M, Duan RD, Nilsson A, Svensson M, Karpman D, Svanborg C. 2001. Fimbriae, transmembrane signaling, and cell activation. J Infect Dis. 183:S47–S50.10.1086/jid.2001.183.issue-s1
  • Hibbing ME, Fuqua C, Parsek MR, Peterson SB. 2010. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol. 8:15–25.10.1038/nrmicro2259
  • Hola V, Ruzicka F, Horka M. 2010. Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques. FEMS Immunol Med Microbiol. 59:525–528.
  • Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 21:26–59.10.1128/CMR.00019-07
  • Joshi F, Archana G, Desai A. 2006. Siderophore cross-utilization amongst rhizospheric bacteria and the role of their differential affinities for Fe3+ on growth stimulation under iron-limited conditions. Curr Microbiol. 53:141–147.10.1007/s00284-005-0400-8
  • Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM. 2007. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 122:160–166.
  • Lambiase A, Catania MR, Del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V. 2011. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 30:973–980.10.1007/s10096-011-1182-5
  • Lenski RE, Rose MR, Simpson SC, Tadler SC. 1991. Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am Nat. 138:1315–1341.10.1086/an.1991.138.issue-6
  • Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 5:48–56.10.1038/nrmicro1557
  • Lopes SP, Ceri H, Azevedo NF, Pereira MO. 2012. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. Int J Antimicrob Agents. 40:260–263.
  • Lopes SP, Azevedo NF, Pereira MO. 2014. Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy. Crit Rev Microbiol. doi:10.3109/1040841X.2013.847898.
  • Lourenco A, Ferreira A, Veiga N, Machado I, Pereira MO, Azevedo NF. 2012. BiofOmics: a web platform for the systematic and standardized collection of high-throughput biofilm data. PloS one. 7:e39960.10.1371/journal.pone.0039960
  • Macleod SM, Stickler DJ. 2007. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol. 56:1549–1557.10.1099/jmm.0.47395-0
  • Matsukawa M, Kunishima Y, Takahashi S, Takeyama K, Tsukamoto T. 2005. Bacterial colonization on intraluminal surface of urethral catheter. Urology. 65:440–444.10.1016/j.urology.2004.10.065
  • Moreira JMR, Gomes LC, Araújo JDP, Miranda JoM, Simões M, Melo LF, Mergulhão FJ. 2013. The effect of glucose concentration and shaking conditions on Escherichia coli biofilm formation in microtiter plates. Chem Eng Sci. 94:192–199.10.1016/j.ces.2013.02.045
  • Morris NS, Stickler DJ. 1998. Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J Hosp Infect. 39:227–234.10.1016/S0195-6701(98)90262-6
  • Niveditha S, Pramodhini S, Umadevi S, Kumar S, Stephen S. 2012. The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J Clin Diagn Res. 6:1478–1482.
  • Oliveira AR, Costa AG, Sousa VE, Araujo TL, Silva VM, Lopes MV, Cardoso MV. 2012. Scales for evaluation of the overload of caregivers of patients with stroke. Rev Bras Enferm. 65:839–843.10.1590/S0034-71672012000500018
  • Patil NK, Kundapur R, Shouche YS, Karegoudar TB. 2006. Degradation of plasticizer di-n-butylphthalate by Delftia sp. TBKNP-05. Curr Microbiol. 52:369–374.10.1007/s00284-005-5258-2
  • Preiswerk B, Ullrich S, Speich R, Bloemberg GV, Hombach M. 2011. Human infection with Delftia tsuruhatensis isolated from a central venous catheter. J Med Microbiol. 60:246–248.10.1099/jmm.0.021238-0
  • Ratledge C, Dover LG. 2000. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 54:881–941.10.1146/annurev.micro.54.1.881
  • Ronald A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 113:14–19.10.1016/S0002-9343(02)01055-0
  • Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal Biochem. 160:47–56.10.1016/0003-2697(87)90612-9
  • Shand GH, Anwar H, Kadurugamuwa J, Brown MR, Silverman SH, Melling J. 1985. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun. 48:35–39.
  • Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG. 2008. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog. 4:e1000184.10.1371/journal.ppat.1000184
  • Silva S, Negri M, Henriques M, Oliveira R, Williams D, Azeredo J. 2010. Silicone colonization by non-Candida albicans Candida species in the presence of urine. J Med Microbiol. 59:747–754.10.1099/jmm.0.017517-0
  • Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D’Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA. 103:8487–8492.10.1073/pnas.0602138103
  • Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun. 72:6373–6381.10.1128/IAI.72.11.6373-6381.2004
  • Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 40:175–179.10.1016/S0167-7012(00)00122-6
  • Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat Rev Microbiol. 6:199–210.10.1038/nrmicro1838
  • Svanborg C, Godaly G. 1997. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am. 11:513–529.10.1016/S0891-5520(05)70371-8
  • Tenke P, Kovacs B, Jackel M, Nagy E. 2006. The role of biofilm infection in urology. World J Urol. 24:13–20.10.1007/s00345-005-0050-2
  • Wan N, Gu JD, Yan Y. 2007. Degradation of p-nitrophenol by Achromobacter xylosoxidans Ns isolated from wetland sediment. Int Biodeterior Biodegrad. 59:90–96.
  • Waters V. 2012. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Curr Pharm Des. 18:696–725.10.2174/138161212799315939
  • Weaver VB, Kolter R. 2004. Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol. 186:2376–2384.10.1128/JB.186.8.2376-2384.2004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.